Pfizer’s Covid Pill Gets Green Light. Investors Are Starting to Pay Attention to the Stock

Dec 23, 2021

Pfizer’s Covid Pill Gets Green Light. Investors Are Starting to Pay Attention to the Stock

The Covid-19 tablet has arrived, and it could not have arrived at a more opportune moment.

The epidemic has intensified over the last two weeks, as the Omicron variety has spread throughout the United States. With the majority of commonly used medicines becoming ineffective as a result of the variant's mutations and case numbers rapidly growing, clinicians and public health officials have grown more concerned.

On Wednesday, the Food and Drug Administration approved Pfizer's (PFE) Covid-19 tablet Paxlovid. The drug has been approved for use only in high-risk people, and initial supplies will be restricted, but it will save lives.

The approval is a remarkable triumph for Pfizer, its second of the epidemic. According to FactSet, analysts anticipate Pfizer to sell $21.7 billion worth of the medicine in 2022, however the firm just announced that it will manufacture 120 million courses of the drug next year, 40 million more than originally expected, likely driving those projections higher.

As Barron's noted in November, Paxlovid's performance demonstrates that the company's choice to divest itself of all but its breakthrough biopharma business in 2019 was a wise one.

Pill Power

https://liquidity-provider.com/app/uploads/2021/12/unnamed-23.png

Both Pfizer and Merck have produced antiviral agents against Covid-19. The following chart illustrates their stock performance.

Investors had been hesitant to embrace the reimagined Pfizer, but they caught up quickly late this year. Prior to November of this year, Pfizer shares lagged the S&P 500 index, despite the company's rollout of the Covid-19 vaccine. However, since the beginning of November, Pfizer's stock has soared. Since then, the stock has gained 36.4 percent, while the S&P 500 has gained just 1.6 percent.

And the company continues to trade at a discount to rivals such as Eli Lilly (LLY), which trades at 31.7 times earnings, and Johnson & Johnson (JNJ), which trades at 16.1 times earnings.

This week's positive news for Pfizer was tempered by bad news for Merck (MRK). Though early results on Merck's Covid-19 tablet molnupiravir drove vaccine stocks lower and Merck shares higher, the drug's luster has since worn off as new data indicate that it is less effective than first indicated and safety concerns persist.

The FDA approved molnupiravir for emergency use on Thursday, a day after it approved Paxlovid, but with far more stringent restrictions. Molnupiravir is authorized for usage only when other Covid-19 medications, such as Paxlovid, are not available or therapeutically acceptable. Additionally, the agency encouraged males who use molnupiravir to utilize reproductive control for at least three months following.

Earlier aspirations for molnupiravir as a long-term income generator are dwindling. The letdown serves as a reminder of the threat that Merck faces before the end of this decade: the expiration of patent protection on Keytruda, the cancer medicine that accounts for nearly a third of its sales. Merck has been attempting to close that gap. Molnupiravir does not appear to be a significant contributor to that endeavor.

Subscribe Our Newsletter

Tesla Could Be Expanding Its Charging Network. Why That Dangerous
Tesla Could Be Expanding Its Charging Network. Why That Dangerous Move Is Justifiable

Charging for Everyone: Tesla seems to be letting owners of other EVs use its charging network. That has one hazard, even though it's probably a wise choice.

Companies
Fed meeting july 2024

Otar

Fed Meeting July 2024: Rates Remain Steady with Potential Cuts in September

The Fed meeting July 2024 keeps interest rates at 5.25%-5.50%. Professionals should watch for potential cuts in September. Find out what it means.

Banks and Finance
B2BROKER Liquidity B2BROKER Liquidity
Sponsored
Otar

The Future of Blockchain Transparency: What is Arkham Intelligence?
Arkham Intelligence transforms the cryptocurrency industry by offering blockchain analysis, preventing fraud, and enhancing safety and transparency.

discover
How Does Polymarket Work? Comprehensive Guide

Constantine

How Does Polymarket Work? Detailed Guide

Discover how Polymarket enables trading on real-world events with blockchain, smart contracts, and oracles for secure, transparent, and reliable predictions.

Trading
Contact us bg

Contact Us

Contact the Liquidity Provider
for any questions and advertising inquiries

    Please fill out this contact form to get in touch with us

    / 3000

    By clicking “Get in touch” button, you agree to the privacy policy

    Successful!
    Thank you for your request.
    We will contact you shortly.
    Close

    Hazem

    Grok vs ChatGPT: What’s the Best AI Assistant You Need in 2025

    Grok vs ChatGPT

    Сonstantine

    How to Choose the Right Liquidity Provider for Your Brokerage

    How to Choose the Right Liquidity Provider for Your Brokerage

    Сonstantine

    Low-Latency Trading Defined: Speed, Strategy and Technology

    Low-Latency Trading Explained

    Hazem

    How Liquidity Depth Affects Slippage in High-Volume Trading

    Liquidity depth and slippage in trading

    Hazem

    What is FIX API Liquidity Connection and How Does it Power Institutional Trading?

    FIX API in institutional trading

    Сonstantine

    OTC Trading Strategies and Technologies to Succeed in Over-the-Counter Markets

    OTC Trading Strategies

    Alexander

    What is OTC Trading? A Complete Guide for 2025

    what is OTC

    Alexander

    Synthetic Futures: A Trader’s Guide to Replicating Positions with Options

    How to Trade Synthetic Futures

    Сonstantine

    Order Book Depth: What It Is And Why It Matters?

    Order Book Depth What It is And Why It Matters

    Alexander

    Spot vs Perpetual Futures: Which Is Right for You?

    Spot vs Perpetual Futures explained

    Hazem

    5 Reasons Traders Are Switching to Perpetual Futures

    5 Reasons to Switch to Perpetual Futures

    Constantine

    Top 3 Liquidity Challenges Facing New Exchanges and How to Solve Them

    Top 3 Liquidity Challenges Facing New Exchanges Today

    Constantine

    Financial Planning in the Cryptocurrency Era — Master Crypto and Digital Asset Strategies

    Financial Planning in the Cryptocurrency Era

    Hazem

    Best Platforms to Trade Perpetual Futures in 2025

    Best platforms to trade perpetual futures in 2025

    Alex

    Top 10 Fintech Website Development Agencies for 2025

    Best Fintech Website Development Agencies for 2025

    Сonstantine

    Internal vs External Range Liquidity In ICT Trading Explained

    Internal vs External Range Liquidity In ICT Trading

    Constantine

    Portfolio Backtesting — Tools, Metrics, and Methods Explained

    Portfolio Backtesting

    Сonstantine

    ICT Trading Explained: Smart Money Concepts, Tools and Setups

    ICT Trading Explained

    Сonstantine

    CFD Trading Strategies: A Practical Guide to Risk and Execution

    CFD Trading Strategies

    Alexander

    What is a Fair Value Gap? A Guide to Trading Market Imbalances

    What is Fair Value Gap

    Vitaliy

    Triangle Patterns in Trading: Mastering Ascending, Descending & Symmetrical Strategies for Maximum Profit

    Triangle Patterns in Trading: Ascending, Descending & Symmetrical Guide

    Alexander

    What Is COTI? Payments, Token & Price Prediction

    What is a COTI coin

    Constantine

    Best Copy Trading Software in 2025

    Best Copy Trading Software in 2025

    Alex

    What Is an AI Agent? The Future of Finance Explained

    AI Agent Explained
    liquidity-provider-logo
    • News
      • Stock Market Forecast
      • Stocks
      • Banks and Finance
      • Companies
      • Crypto
      • Forex
      • AI
      • Technology
      • DeFi
      • NFT
    • Articles
      • Crypto Payments
      • Trading
      • Crypto Exchange Business
      • Forex Business
      • Fintech
      • Liquidity
      • FinTech Awards
      • Blockchain
      • Investing
      • NFT
      • DeFi
    • More
      • Videos
      • Liquidity Providers List
      • Crypto Payment Providers
      • White Label Brokerage Platforms
      • Broker CRM Platforms
    [email protected]

    © 2024 Liquidity Provider. All Rights Reserved

    Privacy Policy Cookie Policy
    This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.